Kalorama Information Subscription Service
Our Kalorama Information Subscription Service provides you online access to Kalorama Information Profile and MarketLooks reports, as we publish them during the 12-month period of your subscription. Our subscription license also grants organization-wide, global, perpetual site license rights to the reports.
Your users gain access to our reports in your Global Personal Library, our secure Web-based repository for the information we deliver. Digital copies (in PDF format) of Kalorama Information reports are posted there and may be downloaded at any time through any Internet-connected browser.
To help you get the utmost value from your subscription, you will also receive:
One bound hard copy of each report as well as a PDF for internal electronic distribution to employees.
In addition, first-time subscribers gain Global Personal Library access to the most current annual archive of Kalorama Information Profile and MarketLooks Reports, published in the 12 months preceding their subscription. Visit the Kalorama Information site for more information about our valuable archives.
Kalorama Information is publishing at least 24 reports in 2004, covering biotechnology, diagnostics, medical devices, and pharmaceuticals. Reports already published or underway include:
Diagnostics for Emerging Infectious Disease Threats Series (3 vols)
The Worldwide Market for Dialysis Equipment, Supplies, and Services
Markets in Facial Cosmetic Surgery and Rejuvenation
U.S. Market for Interventional Radiology Products
Electrical and Magnetic Neurostimulation: Applications and Markets
Biological Sensor and Sensor Systems, 2nd Ed.
The Geriatric Medicine Series: The 45+ Market in the U.S. (3 vols)
Outsourcing in Drug Development: The Contract Research Market
Medicare Reform and the Pharmaceutical Industry
The Worldwide Market for Prescription Dermatological Drugs, 4th Ed.
The Worldwide Market for Generic Biologics
Pharmaceutical Outsourcing Opportunities Post Launch
The U.S. Market for Over-the-Counter Gastrointestinal Drugs
Trends in Cell Therapeutics: Promise and Reality
The Emerging Cancer Vaccines Market
New Trends in High-Throughput Screening
Monoclonal Antibodies in Cancer Therapy
Immunomodulators in Cancer Therapy
We encourage U.S. government customers to use FEDLINK when ordering your Kalorama Information Subscription Service. FEDLINK is available to all government agencies and departments, their libraries and also their operating and staff offices. FEDLINK customers gain a special benefit: access to the entire archive of Kalorama Information Profile and MarketLooks reports, at no additional charge.